These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3086461)

  • 1. Target ricin by coupling to an anti-macrophage monoclonal antibody.
    Kaminski NE; Roberts JF; Guthrie FE
    J Immunopharmacol; 1986; 8(1):15-37. PubMed ID: 3086461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin.
    Youle RJ; Neville DM
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5483-6. PubMed ID: 6968914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
    Collinson AR; Lambert JM; Liu Y; O'Dea C; Shah SA; Rasmussen RA; Goldmacher VS
    Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
    J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
    Vallera DA; Quinones RR; Azemove SM; Soderling CC
    Transplantation; 1984 Apr; 37(4):387-92. PubMed ID: 6231750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the galactose-binding sites of ricin by its linkage to antibody. Specific cytotoxic effects of the conjugates.
    Thorpe PE; Ross WC; Brown AN; Myers CD; Cumber AJ; Foxwell BM; Forrester JT
    Eur J Biochem; 1984 Apr; 140(1):63-71. PubMed ID: 6608447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a monoclonal antibody recognizing a galactose-binding domain of the toxin ricin.
    Colombatti M; Johnson VG; Skopicki HA; Fendley B; Lewis MS; Youle RJ
    J Immunol; 1987 May; 138(10):3339-44. PubMed ID: 2437188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ
    Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.
    Kishida K; Masuho Y; Saito M; Hara T; Fuji H
    Cancer Immunol Immunother; 1983; 16(2):93-7. PubMed ID: 6559105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
    Ramakrishnan S; Houston LL
    Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-ricin B chain conjugate has enhanced biological activity in insulin-insensitive cells.
    Roth RA; Iwamoto Y; Maddux B; Goldfine ID
    Endocrinology; 1983 Jun; 112(6):2193-9. PubMed ID: 6343061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
    Wu M; Tang SL; Zang RJ; Yu H
    Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characteristics associated with the protective efficacy of antibodies to ricin.
    Maddaloni M; Cooke C; Wilkinson R; Stout AV; Eng L; Pincus SH
    J Immunol; 2004 May; 172(10):6221-8. PubMed ID: 15128810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies on the use of selective antibody-ricin conjugates in autologous bone marrow transplantation.
    Leonard JE; Taetle R; To D; Rhyner K
    Blood; 1985 May; 65(5):1149-57. PubMed ID: 3888307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE; Wang QC; Kaplan NO; Royston I
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
    Rasmussen RA; Counts SL; Lambert JM; Collinson AR
    Cancer Immunol Immunother; 1992; 35(5):355-63. PubMed ID: 1394340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
    Shah SA; Lambert JM; Goldmacher VS; Esber HJ; Levin JL; Chungi V; Zutshi A; Braman GM; Ariniello PD; Taylor JA
    Int J Immunopharmacol; 1993 Aug; 15(6):723-36. PubMed ID: 7691767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.